143 related articles for article (PubMed ID: 36172662)
1. Generation and Characterization of Novel Diagnostic Mouse Monoclonal Antibodies Against Human Estrogen Receptor Alpha and Progesterone Receptor.
Hassanzadeh Makoui M; Mobini M; Khoshnoodi J; Judaki MA; Bahadori T; Ahmadi Zare H; Golsaz-Shirazi F; Moradi Tabriz H; Madjd Z; Jeddi-Tehrani M; Zarnani AH; Amiri MM; Shokri F
Asian Pac J Cancer Prev; 2022 Sep; 23(9):2999-3007. PubMed ID: 36172662
[TBL] [Abstract][Full Text] [Related]
2. Novel Monoclonal Antibodies Specific for Human Ki67 and P53 Tumor Markers in Breast Cancer Tissue Samples.
Hassanzadeh Makoui M; Mobini M; Khoshnoodi J; Bahadori T; Golsaz-Shirazi F; Moradi Tabriz H; Madjd Z; Jeddi-Tehrani M; Zarnani AH; Amiri MM; Shokri F
Iran J Immunol; 2023 May; 20(2):177-189. PubMed ID: 37149778
[TBL] [Abstract][Full Text] [Related]
3. Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry.
Rocha R; Nunes C; Rocha G; Oliveira F; Sanches F; Gobbi H
Pathol Res Pract; 2008; 204(9):655-62. PubMed ID: 18565685
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical Performance of Estrogen and Progesterone Receptor Antibodies on the Dako Omnis Staining Platform: Evaluation in Multicenter Studies.
Hicks D; Dell'Orto P; Falzon M; Hoff KD; Levy YY; McMahon L; Miller K; Russo L; Viale G
Appl Immunohistochem Mol Morphol; 2017; 25(5):313-319. PubMed ID: 26657878
[TBL] [Abstract][Full Text] [Related]
5. Receptor conversion in distant breast cancer metastases.
Hoefnagel LD; van de Vijver MJ; van Slooten HJ; Wesseling P; Wesseling J; Westenend PJ; Bart J; Seldenrijk CA; Nagtegaal ID; Oudejans J; van der Valk P; van der Groep P; de Vries EG; van der Wall E; van Diest PJ
Breast Cancer Res; 2010; 12(5):R75. PubMed ID: 20863372
[TBL] [Abstract][Full Text] [Related]
6. Study on breast carcinoma Her2/neu and hormonal receptors status assessed by automated images analysis systems: ACIS III (Dako) and ScanScope (Aperio).
Słodkowska J; Filas V; Buszkiewicz E; Trzeciak P; Wojciechowski M; Koktysz R; Staniszewski W; Breborowicz J; Rojo MG
Folia Histochem Cytobiol; 2010 Jan; 48(1):19-25. PubMed ID: 20529811
[TBL] [Abstract][Full Text] [Related]
7. [Preparation and identification of monoclonal antibodies to estrogen and progesterone receptors].
Sun S; Zhang L; Gong P
Zhonghua Bing Li Xue Za Zhi; 1998 Jun; 27(3):216-9. PubMed ID: 11244986
[TBL] [Abstract][Full Text] [Related]
8. Analytical and clinical performance of progesterone receptor antibodies in breast cancer.
Calhoun BC; Mosteller B; Warren D; Smith M; Jordi Rowe J; Lanigan CP; Mrazeck KC; Walker E; Newell AH; Jones R
Ann Diagn Pathol; 2018 Aug; 35():21-26. PubMed ID: 29758480
[TBL] [Abstract][Full Text] [Related]
9. Comparison of different antibodies for detection of progesterone receptor in breast cancer.
Press M; Spaulding B; Groshen S; Kaminsky D; Hagerty M; Sherman L; Christensen K; Edwards DP
Steroids; 2002 Aug; 67(9):799-813. PubMed ID: 12123792
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.
Vohra P; Buelow B; Chen YY; Serrano M; Vohra MS; Berry A; Ljung BM
Cancer Cytopathol; 2016 Nov; 124(11):828-835. PubMed ID: 27315045
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody characterization of progesterone receptors, estrogen receptors and the stress-responsive protein of 27 kDa (SRP27) in human uterine leiomyoma.
Navarro D; Cabrera JJ; Falcón O; Jiménez P; Ruiz A; Chirino R; López A; Rivero JF; Díaz-Chico JC; Díaz-Chico BN
J Steroid Biochem; 1989; 34(1-6):491-8. PubMed ID: 2626044
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of the topographical relationship between the estrogen- and progesterone receptor in five human breast cancers. A simultaneous demonstration of both nuclear receptors in the same section by using a computer-assisted image processing.
Bonkhoff H; Wernert N
Virchows Arch A Pathol Anat Histopathol; 1989; 414(4):339-44. PubMed ID: 2540591
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies.
Elashry-Stowers D; Zava DT; Speers WC; Edwards DP
Cancer Res; 1988 Nov; 48(22):6462-74. PubMed ID: 3180062
[TBL] [Abstract][Full Text] [Related]
14. Development of standard estrogen and progesterone receptor immunohistochemical assays for selection of patients for antihormonal therapy.
Phillips T; Murray G; Wakamiya K; Askaa J; Huang D; Welcher R; Pii K; Allred DC
Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):325-31. PubMed ID: 17721279
[TBL] [Abstract][Full Text] [Related]
15. [Western blot analysis and flow cytometric analysis of estrogen and progesterone receptors in fixed breast cancer cells].
Tao DD; Jiang M; Wu JH; Feng YD; Gong JP
Ai Zheng; 2004 Mar; 23(3):339-41. PubMed ID: 15025971
[TBL] [Abstract][Full Text] [Related]
16. Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes.
Diep CH; Ahrendt H; Lange CA
Steroids; 2016 Oct; 114():48-58. PubMed ID: 27641443
[TBL] [Abstract][Full Text] [Related]
17. Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer.
Chen L; Chen Y; Xie Z; Luo J; Wang Y; Zhou J; Huang L; Li H; Wang L; Liu P; Shu M; Zhang W; Ke Z
Breast Cancer Res Treat; 2022 Aug; 194(3):517-529. PubMed ID: 35789315
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of BrightGen HR RT-qDx assay to detect nuclear receptors mRNA overexpression in FFPE breast cancer tissue samples for selection of tamoxifen therapy.
Wang HY; Park S; Kim S; Ahn S; Lee D; Kim S; Jung D; Park KH; Lee H
Int J Clin Exp Pathol; 2014; 7(9):5792-800. PubMed ID: 25337220
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
[TBL] [Abstract][Full Text] [Related]
20. Rabbit antibodies for hormone receptors and HER2 evaluation in breast cancer.
Rocha RM; Nunes CB; Sanches FS; Rocha GF; Oliveira FN; Reis-Filho JS; Lambros MB; Gobbi H
Rev Assoc Med Bras (1992); 2009; 55(2):163-8. PubMed ID: 19488652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
